Studies | Participants | Proportion | 95% CI | Heterogeneity | |
1 year to <2 years | |||||
Overall | 62 | 25 770 | 0.12 | 0.09–0.14 | I2=95% |
2011 ATS/ERS/JRS/ALAT guideline | 16 | 2283 | 0.07 | 0.05–0.09 | I2=72% |
2000 ATS/ERS consensus statement | 25 | 2382 | 0.10 | 0.06–0.15 | I2=92% |
Other criteria | 21 | 21 105 | 0.18 | 0.15–0.22 | I2=92% |
Test for difference between subgroups <0.0001 | |||||
2 to <5 years | |||||
Overall | 35 | 20 787 | 0.38 | 0.34–0.42 | I2=94% |
2011 ATS/ERS/JRS/ALAT guideline | 4 | 1026 | 0.25 | 0.08–0.47 | I2=98% |
2000 ATS/ERS consensus statement | 13 | 995 | 0.42 | 0.37–0.47 | I2=54% |
Other criteria | 18 | 18 766 | 0.38 | 0.33–0.43 | I2=94% |
Test for difference between subgroups=0.17 | |||||
≥5 years | |||||
Overall | 32 | 6369 | 0.69 | 0.59–0.78 | I2=98% |
2011 ATS/ERS/JRS/ALAT guideline | 4 | 326 | 0.62 | 0.38–0.83 | I2=93% |
2000 ATS/ERS consensus statement | 9 | 815 | 0.62 | 0.47–0.75 | I2=94% |
Other criteria | 19 | 5228 | 0.74 | 0.62–0.84 | I2=98% |
Test for difference between subgroups=0.37 |
Data are presented as n, unless otherwise stated. ATS: American Thoracic Society; ERS: European Respiratory Society; JRS: Japanese Respiratory Society; ALAT: Latin American Thoracic Association.